A Study of Imvotamab in Active, Refractory Idiopathic Inflammatory Myopathies
Clinical trial NCT06524687 · TERMINATED
Trial details
- NCT number
- NCT06524687
- Sponsor
- IGM Biosciences, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-29
- Primary completion
- 2025-01-21
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.